The gray‑market peptide boom is no longer a fringe curiosity. It has become a growing parallel ecosystem for people who feel conventional medicine is too slow, too restrictive, too expensive, and often not designed for the kinds of outcomes they care about. In this three‑part series we examine that ecosystem: how mistrust of institutions is …

Continue reading “The Peptide Paradox (1): When Institutional Distrust Drives Alternative Science”